Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
VEGF receptor KDR and Flt-1 (v107) (ID# 7631)
Peptide
VEGF receptor KDR and Flt-1
Cells
0.6 µM (reported value)
Binding Buffer (0.5% (v/v) Tween20, 0.5% BSA in PBS)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
NH2-GlyGlyAsnGluCysAspAlaIleArgMetTrpGluTrpGluCysPheGluArgLeu-COOH
19
2606.94
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Pan et al. "Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor." J Mol Biol, 316(2002): 769-787.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.